Study of Visilizumab Versus Placebo in Subjects With Intravenous Steroid-refractory Ulcerative Colitis Previously Responsive in a Visilizumab Study

Summary

The purpose of this study is to compare the efficacy, safety, pharmacokinetics, and immunogenicity in subjects retreated with visilizumab or placebo after a response in a prior visilizumab study.

Timeline

Start

2006-08

Primary completion

2007-08

Completion

2007-08

Outcome

Outcome not reported

Stopped: “company decision based on other studies”

Drugs

Indications